Bellevue Life Sciences Acquisition Insider Trades

BLAC

Track insider trading activity from Bellevue Life Sciences Acquisition executives and directors. See which insiders are buying and selling BLAC stock.

Trades Last 12 Months

BLAC Price

All Insider Trades for Bellevue Life Sciences Acquisition

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Hwang Kuk Hyoun 10% owner, Chief Executive Officer
Holding Value $6.02M 2,000,500 shares
Last Trade
Mar 23, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$202k 20,000 shares
$10.10
$3.01
Yoo David Jin Chief Financial Officer
Holding Value $60.2k 20,000 shares
Last Trade
Mar 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$404k 40,000 shares
$10.10
$3.01
Holding Value $6.08M 2,020,500 shares
Last Trade
Feb 21, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$3.01
Reed Steven Director
Holding Value $60.2k 20,000 shares
Last Trade
Feb 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up